Company Update Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Zydus and Daewoong Pharmaceuticals announce exclusive licensing agreement for development and commercialization of Leuprolide Long-Acting Injectable in the U.S.